APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells
- Resource Type
- Article
- Source
- In
Lung Cancer 2009 66(3):298-304 - Subject
- Language
- ISSN
- 0169-5002